This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Inxmed (Nanjing) Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Xuebin Liu: Innovator in Tumor Treatment
Introduction
Xuebin Liu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of medical research, particularly in the treatment of tumors. His innovative approach combines existing therapies to enhance treatment efficacy.
Latest Patents
Xuebin Liu holds a patent for a drug combination aimed at treating tumors. The patent, titled "Drug combination and use for treating tumors," focuses on the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor. This combination is designed to improve treatment outcomes for patients suffering from various types of tumors.
Career Highlights
Xuebin Liu is associated with Inxmed (Nanjing) Co., Ltd., where he continues to work on groundbreaking research in oncology. His dedication to advancing cancer treatment has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Xuebin Liu has collaborated with notable colleagues, including Baoyuan Zhang and Jiaming Gao. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Xuebin Liu's contributions to tumor treatment through his patented drug combination exemplify his commitment to improving patient care. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile